SWITGLIM-MP2

Composition

Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)

Uses of SWITGLIM-MP2

Treatment of Type 2 diabetes mellitus

• •In Treatment of Type 2 diabetes mellitus Type 2 diabetes is a condition where the body either does not produce enough insulin or cannot use it properly
• •leading to high blood sugar levels. Switglim-MP2/15 Tablet SR helps improve blood sugar control by supporting better use of insulin and reducing excess glucose levels in the body. It helps maintain more stable sugar levels throughout the day
• •lowers the risk of diabetes-related complications
• •and supports overall metabolic health when used along with a proper diet and lifestyle.

How it works

Switglim-MP2/15 Tablet SR is a combination of three antidiabetic medicines: Glimepiride, Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, reducing glucose absorption from the intestines, and increasing the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione, which further increases insulin sensitivity.

Directions for use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Switglim-MP2/15 Tablet SR should be taken with or after food.

Side effects